Impact of statin therapy on clinical outcomes in chronic heart failure patients according to beta-blocker use: Results of CIBIS II

Henry Krum; Michael John Bailey; Wilfried Meyer; Patricia Verkenne; Henry Dargie; Phillipe Lechat; Stefan D Anker

doi:10.1159/000095629

Impact of statin therapy on clinical outcomes in chronic heart failure patients according to beta-blocker use: Results of CIBIS II

Henry Krum
, Michael John Bailey
, Wilfried Meyer
, Patricia Verkenne
, Henry Dargie
, Phillipe Lechat
, Stefan D Anker

Epidemiology and Preventive Medicine Alfred Hospital

Research output: Contribution to journal › Article › Research › peer-review

27 Citations (Scopus)

Abstract

BACKGROUND: HMG-CoA reductase inhibitors (statins) are widely prescribed in patients with established systolic chronic heart failure (CHF). However, there is considerable controversy regarding their benefit in this setting. We therefore conducted a post-hoc analysis of outcomes according to statin use within the Second Cardiac Insufficiency Bisoprolol Study of the beta-blocker, bisoprolol, in NYHA classes III-IV systolic CHF patients (left ventricular ejection fraction

Original language	English
Pages (from-to)	28 - 34
Number of pages	7
Journal	Cardiology
Volume	108
Issue number	1
DOIs	https://doi.org/10.1159/000095629
Publication status	Published - 2007

Access to Document

10.1159/000095629

Cite this

@article{2ca54521dcd34719a27d9e177c266506,

title = "Impact of statin therapy on clinical outcomes in chronic heart failure patients according to beta-blocker use: Results of CIBIS II",

abstract = "BACKGROUND: HMG-CoA reductase inhibitors (statins) are widely prescribed in patients with established systolic chronic heart failure (CHF). However, there is considerable controversy regarding their benefit in this setting. We therefore conducted a post-hoc analysis of outcomes according to statin use within the Second Cardiac Insufficiency Bisoprolol Study of the beta-blocker, bisoprolol, in NYHA classes III-IV systolic CHF patients (left ventricular ejection fraction",

author = "Henry Krum and Bailey, \{Michael John\} and Wilfried Meyer and Patricia Verkenne and Henry Dargie and Phillipe Lechat and Anker, \{Stefan D\}",

year = "2007",

doi = "10.1159/000095629",

language = "English",

volume = "108",

pages = "28 -- 34",

journal = "Cardiology",

issn = "0008-6312",

publisher = "S Karger AG",

number = "1",

}

TY - JOUR

T1 - Impact of statin therapy on clinical outcomes in chronic heart failure patients according to beta-blocker use: Results of CIBIS II

AU - Krum, Henry

AU - Bailey, Michael John

AU - Meyer, Wilfried

AU - Verkenne, Patricia

AU - Dargie, Henry

AU - Lechat, Phillipe

AU - Anker, Stefan D

PY - 2007

Y1 - 2007

N2 - BACKGROUND: HMG-CoA reductase inhibitors (statins) are widely prescribed in patients with established systolic chronic heart failure (CHF). However, there is considerable controversy regarding their benefit in this setting. We therefore conducted a post-hoc analysis of outcomes according to statin use within the Second Cardiac Insufficiency Bisoprolol Study of the beta-blocker, bisoprolol, in NYHA classes III-IV systolic CHF patients (left ventricular ejection fraction

AB - BACKGROUND: HMG-CoA reductase inhibitors (statins) are widely prescribed in patients with established systolic chronic heart failure (CHF). However, there is considerable controversy regarding their benefit in this setting. We therefore conducted a post-hoc analysis of outcomes according to statin use within the Second Cardiac Insufficiency Bisoprolol Study of the beta-blocker, bisoprolol, in NYHA classes III-IV systolic CHF patients (left ventricular ejection fraction

UR - http://content.karger.com/ProdukteDB/produkte.asp?Aktion=ShowPDF&ArtikelNr=95629&Ausgabe=232204&ProduktNr=223832&filename=95629.pdf

U2 - 10.1159/000095629

DO - 10.1159/000095629

M3 - Article

SN - 0008-6312

VL - 108

SP - 28

EP - 34

JO - Cardiology

JF - Cardiology

IS - 1

ER -

Impact of statin therapy on clinical outcomes in chronic heart failure patients according to beta-blocker use: Results of CIBIS II

Abstract

Access to Document

Other files and links

Cite this